August 20, 2024
CARLSBAD, California — Posting on social media may not be your cup of tea, but in the opinion of Jessica G. Labadie, MD, avoiding a presence […]
August 19, 2024
CARLSBAD, California — The level of training and supervision among individuals who perform cosmetic procedures at medical spas (MedSpas) varies widely, a trend that patients may […]
August 16, 2024
CARLSBAD, California — In 2003, researchers asked 303 patients with systemic sclerosis (scleroderma) what bothered them most about their disease from an aesthetic standpoint: Orofacial features, […]
August 14, 2024
TOPLINE: Hispanic patients with dermatomyositis are diagnosed at a younger age, exhibit different clinical manifestations, and are more likely to have a different autoantibody than non-Hispanic […]
August 14, 2024
TOPLINE: Among patients with severe alopecia areata (AA) who have significant hair growth with baricitinib, continuing treatment is needed to maintain hair regrowth, according to the […]
August 13, 2024
On August 13, 2024, the US Food and Drug Administration (FDA) approved nemolizumab for the treatment of adults with prurigo nodularis (PN). A first-in-class monoclonal antibody […]
August 13, 2024
WASHINGTON, DC — Cutaneous immune-related adverse events (cirAEs) in oncology patients receiving immune checkpoint inhibitors (ICIs) should be treated in as targeted a fashion as possible […]
May 30, 2024
TOPLINE: Black patients with psoriasis are less likely to switch biologic therapies than patients in other racial and ethnic groups, indicating possible differences in treatment patterns. […]
May 29, 2024
Children with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with dupilumab demonstrated significant hair regrowth over a mean of nearly 68 weeks, […]